Search research articles
Contact Us
Filters
Showing results (61-70 of 171) with videos related to
Page
of 18
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 1997
A retrospective cost-effectiveness analysis of interferon as adjuvant therapy in high-risk resected cutaneous melanoma
A Messori, P Becagli, S Trippoli, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 12, 2010
Risk-sharing approach for managing factor VIIa reimbursement in haemophilia patients with inhibitors
A Messori, S Trippoli, M Innocenti, et al.
Bone Marrow Transplantation
|
February 1, 1997
Cost-effectiveness of autologous bone marrow transplantation in patients with relapsed non-Hodgkin's lymphoma
A Messori, L Bonistalli, M Costantini, et al.
Journal of Endocrinological Investigation
|
November 22, 2014
Gastrointestinal and renal side effects of bisphosphonates: differentiating between no proof of difference and proof of no difference
V Fadda, D Maratea, S Trippoli, et al.
Alimentary Pharmacology & Therapeutics
|
June 20, 2014
Letter: estimating the cost-neutral price of sofosbuvir-based triple therapy for the treatment of naïve patients with genotype 1 HCV infection in Italy
A Messori, D Maratea, V Fadda, et al.
Alimentary Pharmacology & Therapeutics
|
June 3, 2011
Single-drug treatments for chronic hepatitis B: summarising current information by network meta-analysis
A Messori, F Del Santo, D Maratea, et al.
The New England Journal of Medicine
|
August 3, 1989
Pharmacokinetics of recombinant antihemophilic factor
G Longo, A Messori, M Morfini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 22, 2017
Incidence of low-titre factor VIII inhibitors in patients with haemophilia A: meta-analysis of observational studies
A Messori, F Peyvandi, D Mengato, et al.
Oncology Reports
|
October 14, 1998
Treatments for newly diagnosed multiple myeloma: analysis of survival data and cost-effectiveness evaluation
S Trippoli, A Messori, P Becagli, et al.
European Journal of Clinical Pharmacology
|
December 20, 2003
Dropout rates with olanzapine or risperidone: a multi-centre observational study
F Pelagotti, B Santarlasci, F Vacca, et al.
Page
of 18
Search research articles
Search
Showing results (61-70 of 171) with videos related to
Sort By:
Page
of 18
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 1997
A retrospective cost-effectiveness analysis of interferon as adjuvant therapy in high-risk resected cutaneous melanoma
A Messori, P Becagli, S Trippoli, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 12, 2010
Risk-sharing approach for managing factor VIIa reimbursement in haemophilia patients with inhibitors
A Messori, S Trippoli, M Innocenti, et al.
Bone Marrow Transplantation
|
February 1, 1997
Cost-effectiveness of autologous bone marrow transplantation in patients with relapsed non-Hodgkin's lymphoma
A Messori, L Bonistalli, M Costantini, et al.
Journal of Endocrinological Investigation
|
November 22, 2014
Gastrointestinal and renal side effects of bisphosphonates: differentiating between no proof of difference and proof of no difference
V Fadda, D Maratea, S Trippoli, et al.
Alimentary Pharmacology & Therapeutics
|
June 20, 2014
Letter: estimating the cost-neutral price of sofosbuvir-based triple therapy for the treatment of naïve patients with genotype 1 HCV infection in Italy
A Messori, D Maratea, V Fadda, et al.
Alimentary Pharmacology & Therapeutics
|
June 3, 2011
Single-drug treatments for chronic hepatitis B: summarising current information by network meta-analysis
A Messori, F Del Santo, D Maratea, et al.
The New England Journal of Medicine
|
August 3, 1989
Pharmacokinetics of recombinant antihemophilic factor
G Longo, A Messori, M Morfini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 22, 2017
Incidence of low-titre factor VIII inhibitors in patients with haemophilia A: meta-analysis of observational studies
A Messori, F Peyvandi, D Mengato, et al.
Oncology Reports
|
October 14, 1998
Treatments for newly diagnosed multiple myeloma: analysis of survival data and cost-effectiveness evaluation
S Trippoli, A Messori, P Becagli, et al.
European Journal of Clinical Pharmacology
|
December 20, 2003
Dropout rates with olanzapine or risperidone: a multi-centre observational study
F Pelagotti, B Santarlasci, F Vacca, et al.
Page
of 18